{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:24:57Z","timestamp":1791645897070,"version":"4.3.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":1694,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100006221","name":"Cordis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006221","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Interventions"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.jcin.2008.06.012","type":"journal-article","created":{"date-parts":[[2009,1,21]],"date-time":"2009-01-21T15:40:44Z","timestamp":1232552444000},"page":"37-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":142,"title":["In-Hospital and 1-Year Outcomes Among Percutaneous Coronary Intervention Patients With Chronic Kidney Disease in the Era of Drug-Eluting Stents"],"prefix":"10.1016","volume":"2","author":[{"given":"Faisal","family":"Latif","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal S.","family":"Kleiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Pencina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Hsing","family":"Yen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald E.","family":"Cutlip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Moliterno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Nassif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge F.","family":"Saucedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcin.2008.06.012_bib1","series-title":"USRDS 2006 Annual Data Report: Atlas of End-Stage Renal Disease in the United States","year":"2006"},{"key":"10.1016\/j.jcin.2008.06.012_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/ajkd.2003.50007","article-title":"Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey","volume":"41","author":"Coresh","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jcin.2008.06.012_bib3","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1161\/01.CIR.102.24.2966","article-title":"Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era?","volume":"102","author":"Rubenstein","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2008.06.012_bib4","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0735-1097(02)01745-X","article-title":"The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions","volume":"39","author":"Best","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2008.06.012_bib5","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0002-8703(05)80268-6","article-title":"Short and long-term outcome of percutaneous trans-luminal coronary angioplasty in chronic dialysis patients","volume":"119","author":"Kahn","year":"1990","journal-title":"Am Heart J"},{"key":"10.1016\/j.jcin.2008.06.012_bib6","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/0003-4975(96)00170-1","article-title":"Comparison of clinical outcomes of coronary artery bypass grafting and percutaneous trans-luminal coronary angioplasty in renal dialysis patients","volume":"61","author":"Koyangi","year":"1996","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jcin.2008.06.012_bib7","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1001\/jama.296.11.1377","article-title":"Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease","volume":"296","author":"Coca","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jcin.2008.06.012_bib8","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.ahj.2005.03.030","article-title":"Design of a registry to characterize \u201creal-world\u201d outcomes of percutaneous coronary revascularization in the drug-eluting stent era","volume":"150","author":"Jacob","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.jcin.2008.06.012_bib9","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1001\/jama.297.18.2001","article-title":"Clinical outcomes and stent thrombosis following off-label use of drug eluting stents","volume":"297","author":"Win","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jcin.2008.06.012_bib10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"10.1016\/j.jcin.2008.06.012_bib11","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0735-1097(01)01344-4","volume":"37","author":"Smith","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2008.06.012_bib12","doi-asserted-by":"crossref","first-page":"256","DOI":"10.7326\/0003-4819-115-4-256","article-title":"Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial","volume":"115","author":"Bovill","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jcin.2008.06.012_bib13","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1161\/01.CIR.0000103623.63687.21","article-title":"Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction","volume":"108","author":"Sadeghi","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2008.06.012_bib14","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1345\/aph.1G057","article-title":"Percutaneous coronary intervention-related bleeding risk factors in current practice","volume":"39","author":"Mathis","year":"2005","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jcin.2008.06.012_bib15","doi-asserted-by":"crossref","first-page":"412","DOI":"10.5414\/CNP64412","article-title":"Risk of bleeding and restenosis among chronic kidney disease patients undergoing percutaneous coronary intervention","volume":"64","author":"Attallah","year":"2005","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.jcin.2008.06.012_bib16","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.ahj.2004.12.002","article-title":"The relation of renal function to ischemic and bleeding outcomes with 2 different glycoprotein IIb\/IIIa inhibitors: the do Tirofiban and ReoPro Give Similar Efficacy Outcome (TARGET) trial","volume":"149","author":"Berger","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.jcin.2008.06.012_bib17","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1001\/jama.294.24.3108","article-title":"Excess dosing of antiplatelet and antithrombin agents in the treatment of non\u2013ST-segment elevation acute coronary syndromes","volume":"294","author":"Alexander","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jcin.2008.06.012_bib18","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1161\/CIRCULATIONAHA.106.620815","article-title":"Sex differences in major bleeding with glycoprotein IIb\/IIIa inhibitors: results from the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC\/AHA guidelines) initiative","volume":"114","author":"Alexander","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2008.06.012_bib19","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1067\/mhj.2003.168","article-title":"Anticoagulation in acute cardiac care in patients with chronic kidney disease","volume":"145","author":"Reddan","year":"2003","journal-title":"Am Heart J"},{"key":"10.1016\/j.jcin.2008.06.012_bib20","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/ajh.2830350306","article-title":"Selective reduction of serotonin storage and ATP release in chronic renal failure patients platelets","volume":"35","author":"Soslau","year":"1990","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jcin.2008.06.012_bib21","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.ahj.2005.01.032","article-title":"Impact of moderate renal insufficiency on restenosis and adverse clinical events after paclitaxel-eluting and bare metal stent implantation: results from the TAXUS-IV trial","volume":"150","author":"Halkin","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.jcin.2008.06.012_bib22","first-page":"405","article-title":"Impact of drug-eluting stents on outcomes of patients with end-stage renal disease undergoing percutaneous coronary revascularization","volume":"18","author":"Das","year":"2006","journal-title":"J Inv Cardiol"},{"key":"10.1016\/j.jcin.2008.06.012_bib23","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1097\/00029330-200607020-00007","article-title":"Long term clinical outcomes in patients with moderate renal insufficiency undergoing stent based percutaneous coronary intervention","volume":"119","author":"Zhang","year":"2006","journal-title":"Chin Med J"},{"key":"10.1016\/j.jcin.2008.06.012_bib24","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0735-1097(02)02666-9","article-title":"Intravenous glycoprotein IIb\/IIIa receptor antagonists reduce mortality after percutaneous coronary interventions","volume":"41","author":"Karvouni","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2008.06.012_bib25","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.amjcard.2004.08.089","article-title":"Impact of baseline renal function on mortality after percutaneous coronary intervention with sirolimus-eluting stents or bare metal stents","volume":"95","author":"Lemos","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcin.2008.06.012_bib26","first-page":"808","article-title":"Impact of renal insufficiency on clinical and angiographic outcomes following percutaneous coronary intervention with sirolimus-eluting stents","volume":"69","author":"Nakazawa","year":"2007","journal-title":"Cath Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2008.06.012_bib27","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1001\/jama.293.17.2126","article-title":"Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents","volume":"293","author":"Iakovou","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jcin.2008.06.012_bib28","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1053\/ajkd.2001.22070","article-title":"Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency","volume":"37","author":"Tonelli","year":"2001","journal-title":"Am J Kidney Dis"}],"container-title":["JACC: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879808004494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879808004494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:55:41Z","timestamp":1761846941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879808004494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S1936879808004494"],"URL":"https:\/\/doi.org\/10.1016\/j.jcin.2008.06.012","relation":{},"ISSN":["1936-8798"],"issn-type":[{"value":"1936-8798","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In-Hospital and 1-Year Outcomes Among Percutaneous Coronary Intervention Patients With Chronic Kidney Disease in the Era of Drug-Eluting Stents","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Interventions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2008.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}